Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
39 hedge funds and large institutions have $33M invested in Chembio diagnostics, Inc. in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 10 closing their positions.
89% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 9
1.26% less ownership
Funds ownership: 42.02% → 40.76% (-1.3%)
13% less funds holding
Funds holding: 45 → 39 (-6)
27% less capital invested
Capital invested by funds: $45.2M → $33M (-$12.1M)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$1.83M |
| 2 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$424K |
| 3 |
PM
Penbrook Management
New York
|
+$193K |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$187K |
| 5 |
BlackRock
New York
|
+$120K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$1.02M |
| 2 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$907K |
| 3 |
AIP
ARS Investment Partners
New York
|
-$617K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$408K |
| 5 |
RC
Roubaix Capital
Denver,
Colorado
|
-$333K |
CEMI Hedge Fund Activity: Q4 2019 in Review
39 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q4 2019, worth a combined $33M — down 27% from $45.2M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of CEMI and 4 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 17 added.
The largest buyer was Royce & Associates, adding an estimated $1.83M. The largest seller was Wells Fargo, cutting an estimated $1.02M.
- 39 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q4 2019, down from 45 in Q3 2019.
- Funds reported $33M of Chembio diagnostics, Inc. stock for Q4 2019, down 27% quarter-over-quarter.
- 4 funds opened new Chembio diagnostics, Inc. positions in Q4 2019 and 10 closed out, a net change of -6 holders.
- The largest Chembio diagnostics, Inc. buyer in Q4 2019 was Royce & Associates, an estimated $1.83M added.
- The largest Chembio diagnostics, Inc. seller in Q4 2019 was Wells Fargo, an estimated $1.02M sold.
Based on aggregated 13F filings for Q4 2019.